Sparrow Pharmaceuticals Revenue

Pharmaceutical Manufacturing • Portland, Oregon, United States • 11-20 Employees

Sparrow Pharmaceuticals revenue & valuation

Annual revenue	$5,000,000
Revenue per employee	$334,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$16,000,000
Total funding	$217,000,000

Key Contact at Sparrow Pharmaceuticals

Sarah Hooper

Director of Clinical Operations at Sparrow Pharmaceuticals, Inc

Company overview

Headquarters	920 SW 6th Ave, Suite 1200, Portland, Oregon 97204, US
Phone number	+16174650328
Website	sparrowpharma.com
NAICS	3254
SIC	283
Keywords	Pharmaceuticals, Clinical Trials, Drug Development, Inflammatory Diseases, Corticosteroids, Autoimmune Diseases, Giant Cell Arteritis, New Chemical Entity, Polymyalgia Rheumatica, Cushing'S Syndrome
Founded	2013
Employees	11-20
Socials

Sparrow Pharmaceuticals Email Formats

Sparrow Pharmaceuticals uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@sparrowpharma.com), used 53.8% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@sparrowpharma.com	53.8%
{first initial}{last name}	jdoe@sparrowpharma.com	38.5%
{first initial}	j@sparrowpharma.com	7.7%

About Sparrow Pharmaceuticals

Sparrow Pharmaceuticals is a targeted cardiometabolic therapeutics company delivering improved outcomes for millions of patients who struggle to control their disease with current options for diabetes and related metabolic conditions. The Company’s lead candidate, clofutriben, is a first-in-class, once-daily, oral HSD-1 inhibitor initially in development for type 2 diabetes with elevated cortisol. HSD-1 inhibition targets an underlying etiology of treatment resistance across the spectrum of metabolic dysfunction and is complementary to leading antidiabetic agents. Sparrow is led by an experienced team of biotech executives, endocrinologists, and drug development veterans with a shared commitment to precision medicine in metabolic disease.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

Funding Data

Explore Sparrow Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2021-06-18	4	$50,000,000
2024-05-24	1	$10,200,000
2025-08-01	1	$61,800,000
2025-10-24	5	$95,000,000

Funding Insights

$217,000,000

Total funding amount

$95,000,000

Most recent funding amount

Number of funding rounds

Sparrow Pharmaceuticals Tech Stack

Discover the technologies and tools that power Sparrow Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

Amazon Web Services

PaaS

Squarespace Commerce

Ecommerce

Emotion

Development

reCAPTCHA

Security

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Cart Functionality

Ecommerce

Frequently asked questions

Sparrow Pharmaceuticals is located in Portland, Oregon, US.

You can reach Sparrow Pharmaceuticals at +16174650328.

Sparrow Pharmaceuticals generates an estimated annual revenue of $5,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Sparrow Pharmaceuticals has an estimated valuation of $16,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Sparrow Pharmaceuticals was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

Sparrow Pharmaceuticals has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Sparrow Pharmaceuticals has raised a total of $217,000,000 across 4 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Sparrow Pharmaceuticals

Sarah Hooper

Director of Clinical Operations at Sparrow Pharmaceuticals, Inc

4.8

40,000 users